XPC gene polymorphisms contribute to bladder cancer susceptibility: A meta-analysis

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 447-453

  Dai, Qiang Sheng ^a   Hua, Rui Xi ^a   Zeng, Rui Fang ^a   Long, Jian Ting ^a   Peng, Zhen Wei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bladder cancer; Meta analysis; Polymorphism; Susceptibility; XPC

Indexed keywords

GLUTAMINE; LYSINE; VALINE;

ALLELE; ARTICLE; ASIAN; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; ONCOGENE; PRIORITY JOURNAL; XPC GENE;

ALLELES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK; URINARY BLADDER NEOPLASMS;

EID: 84894477073     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1062-y     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030-44.
3. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22-33.
4. De Silva IU,McHugh PJ, Clingen PH, Hartley JA. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol. 2000;20:7980-90.
5. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epid Bio Prev. 2002;11:1513-30.
6. Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell. 1998;2:223-32.
7. Thoma BS, Vasquez KM. Critical DNA damage recognition functions of XPC-hHR23B and XPA-RPA in nucleotide excision repair. Mol Carcinog. 2003;38:1-13.
8. Wood RD. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie. 1999;81:39-44.
9. Rouissi K, Ouerhani S, Hamrita B, Bougatef K, Marrakchi R, et al. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia. Pathol Oncol Res. 2011;17:879-86.
10. Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:536-42.
11. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J Cancer. 2005;92:2262-5.
12. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cyclecontrol genes. Am J Hum Genet. 2006;78:464-79.
13. Fontana L, Bosviel R, Delort L, Guy L, Chalabi N, et al. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res. 2008;28:1853-6.
14. de Verdier PJ, Sanyal S, Bermejo JL, Steineck G, Hemminki K, et al. Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients. Mutat Res. 2010;694:39-44.
15. Gangwar R, Mandhani A, Mittal RD.XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. J Cancer Res Clin Oncol. 2010;136:779-86.
16. Rouissi K, Bahria IB, Bougatef K, Marrakchi R, Stambouli N, et al. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer. 2011;11:101.
17. Mittal RD, Mandal RK. Genetic variation in nucleotide excision repair pathway genes influence prostate and bladder cancer susceptibility in North Indian population. Indian J Hum Genet. 2012;18:47-55.
18. Liu Y, Wang H, Lin T, Wei Q, Zhi Y, et al. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk. Oncol Rep. 2012;28:337-45.
19. Wen H, Ding Q, Fang ZJ, Xia GW, Fang J. Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai. Int Urol Nephrol. 2009;41:855-64.
20. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis. 2004;25:729-34.
21. Zhu Y, LaiM, Yang H, Lin J, HuangM, et al. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer. Carcinogenesis. 2007;28:698-703.
22. Zhi Y, Yu J, Liu Y, Wei Q, Yuan F, et al. Interaction between polymorphisms of DNA repair genes significantlymodulated bladder cancer risk. Int J Med Sci. 2012;9:498-505.
23. Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, et al. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res. 2009;69:6857-64.
24. Broberg K, Bjork J, Paulsson K, Hoglund M, AlbinM. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005;26:1263-71.
25. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Canc Epi Bio Prev. 2006;15:2537-41.
26. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis. 2006;27:1030-7.
27. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
28. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
29. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test.BMJ. 1997;315:629-34.
30. Qiu L, Wang Z, Shi X. Associations between XPC polymorphisms and risk of cancers: a meta-analysis. Eur J Cancer. 2008;44:2241-53.
31. Zhang D, Chen C, Fu X, Gu S, Mao Y, et al. A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk. J Hum Genet. 2008;53:18-33.
32. Francisco G, Menezes PR, Eluf-Neto J, Chammas R. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet. 2008;16:724-34.
33. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604-8.
34. Khan SG, Metter EJ, Tarone RE, Bohr VA, Grossman L, et al. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcinogenesis. 2000;21:1821-5.